Cardiomyopathy Due to Anthracyclines
Symptoms, Doctors, Treatments, Advances & More

Cardiomyopathy Due to Anthracyclines Overview

Save information for later
Sign Up

Learn About Cardiomyopathy Due to Anthracyclines

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Cardiomyopathy Due to Anthracyclines Local Doctors?
Elite in Cardiomyopathy Due to Anthracyclines
Internal Medicine
Elite in Cardiomyopathy Due to Anthracyclines
Internal Medicine

CVI - Cardiovascular Clinic

330 Brookline Avenue, Shapiro 7, 
Boston, MA 
Experience:
18+ years
Languages Spoken:
English

Aarti Asnani is an Internal Medicine provider practicing medicine in Boston, Massachusetts. She has been practicing medicine for over 18 years. Dr. Asnani is rated as an Elite provider by MediFind in the treatment of Cardiomyopathy Due to Anthracyclines. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Doxorubicin-Induced Cardiomyopathy, Cardiomyopathy Due to Anthracyclines, Myocarditis, Cardiomyopathy, and Pacemaker Implantation. Dr. Asnani is board certified in American Board Of Internal Medicine.

Elite in Cardiomyopathy Due to Anthracyclines
Cardiology
Elite in Cardiomyopathy Due to Anthracyclines
Cardiology
Referral may be required

Brigham And Women's Hospital, Heart And Vascular Center

70 Francis Street, Carl J. And Ruth Shapiro Cardiovascular Center, 
Boston, MA 
Languages Spoken:
English
Offers Telehealth

Dr. Anju Nohria is the Director of the Cardio-Oncology Program at Dana-Farber Brigham Cancer Center and a cardiovascular medicine specialist at Brigham and Women’s Hospital (BWH). In addition, she is an Associate Professor of Medicine at Harvard Medical School (HMS).Dr. Nohria received her medical degree from HMS. She completed an internal medicine residency and was a chief resident at Yale-New Haven Hospital. She then completed both a cardiovascular medicine fellowship and a heart failure and transplantation fellowship at BWH. She is board certified in cardiovascular disease and heart failure and transplantation.Dr. Nohria’s clinical interests include cardio-oncology and heart failure and transplantation. The author of over 100 peer-reviewed publications, she currently researches how to evaluate, prevent and treat cardiovascular complications that can arise as a consequence of cancer therapy. Dr. Nohria is rated as an Elite provider by MediFind in the treatment of Cardiomyopathy Due to Anthracyclines. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Myocarditis, Cardiomyopathy Due to Anthracyclines, Cardiomyopathy, Cardiac Ablation, and Heart Transplant. Dr. Nohria is board certified in Cardiovascular Disease and Advanced Heart Failure And Transplant Cardiology.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Cardiomyopathy Due to Anthracyclines
Cardiology
Elite in Cardiomyopathy Due to Anthracyclines
Cardiology
Referral may be required

Massachusetts General Hospital

55 Fruit St, 
Boston,, MA 
Languages Spoken:
English
Offers Telehealth

Tomas Neilan is a Cardiologist practicing medicine in Boston,, Massachusetts. Dr. Neilan is rated as an Elite provider by MediFind in the treatment of Cardiomyopathy Due to Anthracyclines. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Myocarditis, Cardiomyopathy Due to Anthracyclines, Cardiomyopathy, Heart Transplant, and Cardiac Ablation.

What are the latest Cardiomyopathy Due to Anthracyclines Clinical Trials?
Clinical Study to Evaluate the Possible Safety and Efficacy of Dapagliflozin in the Prophylaxis of Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients

Summary: This is a randomized controlled clinical trial that aims to evaluate the safety and efficacy of Dapagliflozin as a cardioprotective in doxorubicin-induced cardiotoxicity in breast cancer patients.

Match to trials
Find the right clinical trials for you in under a minute
Get started
ANTICIPATE: Prevention of ANThracycline-Induced Cardiac Dysfunction by Dexrazoxane In PATients With diffusE Large B-cell Lymphoma: a Phase III National Multicenter Prospective Randomized Open-label Trial

Summary: Patients treated for DLBCL are at high risk of developing AICD. This adverse event is characterized by irreversible damage to the heart muscle with a loss of cardiomyocytes and subsequent decline in cardiac pumping capacity. Thereby patients treated for this malignancy are at double the risk of developing symptomatic heart failure / cardiomyopathy when compared to the general population. This corr...